{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:04:07Z","timestamp":1749269047954,"version":"3.41.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["Sanofi"],"award-info":[{"award-number":["Sanofi"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The predominant etiologies of splenomegaly (SM) are readily discernible through routine clinical assessments, yet in numerous instances, the etiological basis remains elusive. Subsequent diagnostic steps are not consensual and are challenging for physicians due to miscellaneous causes and non-specific symptoms. This study aimed to estimate the prevalence of Gaucher disease (GD) and other etiologies in patients presenting with unexplained splenomegaly (SM) after exclusion of first intention-diagnoses (e.g., portal hypertension, hematological malignancy, hemolytic anemia, and infection) based on basic physical examination, patient interview, and routine biological exams (e.g., full blood count, liver enzymes, and reticulocyte count). Additionally, the study aimed to describe the diagnostic tests performed and the most frequent associations observed. This French prospective, observational, multicenter, longitudinal SMS study enrolled 505 patients from September 2015 to April 2020, aged\u2009\u2265\u200915 years, referred to hematology or internal medicine departments, with a diagnostically confirmed SM (spleen length\u2009\u2265\u200913\u00a0cm). SM was defined as unexplained when routine clinical and biological tests were negative. Patients were followed up until an etiology was identified or up to 18 months after inclusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>An etiology of SM was found in 223 (44.5%) of 501 patients with follow up. Patients with explained SM were older, had a larger spleen, and had altered biological parameters compared with patients with unexplained SM. There was a higher prevalence of non-malignant diseases than hematological malignancies (27.1% vs. 17.0%). Overall, lysosomal storage diseases (LSDs) were diagnosed in 10 patients (2.0%), including 4 patients with GD (0.8%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A list of potential predictive factors for the main diagnostic categories was identified that could optimize the diagnostic strategy for unexplained SM. This study provides new insights into exploring SM in the real world and proposes clinical and biological factors associated with specific etiologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial registration<\/jats:title>\n            <jats:p>NCT04430881.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03768-3","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:48:10Z","timestamp":1749206890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SplenoMegaly study (SMS): exploring the etiologies for \u201cunexplained\u201d splenomegalies in the real world"],"prefix":"10.1186","volume":"20","author":[{"given":"Guillaume","family":"Denis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Sen\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regis","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Lagadec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Bauduer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Sanhes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Urbanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"2","key":"3768_CR1","first-page":"88","volume":"169","author":"RA O\u2019Reilly","year":"1998","unstructured":"O\u2019Reilly RA. Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients. West J Med. 1998;169(2):88\u201397.","journal-title":"West J Med"},{"key":"3768_CR2","unstructured":"Chapman J, Goyal A, Azevedo AM. Splenomegaly. StatPearls. Treasure Island (FL): StatPearls publishing copyright \u00a9 2023. StatPearls Publishing LLC.; 2023."},{"key":"3768_CR3","first-page":"43","volume":"64","author":"S Srisajjakul","year":"2012","unstructured":"Srisajjakul S, Prapaisilp P, Laorratkul N. Normal Splenic volume assessment on CT in 426 adults. Siriraj Med J. 2012;64:43\u20136.","journal-title":"Siriraj Med J"},{"issue":"27","key":"3768_CR4","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059\u201368.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3768_CR5","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00261-018-1500-9","volume":"43","author":"I Kucyba\u0142a","year":"2018","unstructured":"Kucyba\u0142a I, Ciuk S, T\u0119czar J. Spleen enlargement assessment using computed tomography: which coefficient correlates the strongest with the real volume of the spleen? Abdom Radiol (NY). 2018;43(9):2455\u201361.","journal-title":"Abdom Radiol (NY)"},{"issue":"11","key":"3768_CR6","doi-asserted-by":"publisher","first-page":"e0186674","DOI":"10.1371\/journal.pone.0186674","volume":"12","author":"E Curovic Rotbain","year":"2017","unstructured":"Curovic Rotbain E, Lund Hansen D, Schaffalitzky de Muckadell O, Wibrand F, Meldgaard Lund A, Frederiksen H. Splenomegaly - Diagnostic validity, work-up, and underlying causes. PLoS ONE. 2017;12(11):e0186674.","journal-title":"PLoS ONE"},{"issue":"2","key":"3768_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000040975","volume":"102","author":"J Swaroop","year":"1999","unstructured":"Swaroop J, O\u2019Reilly RA. Splenomegaly at a university hospital compared to a nearby County hospital in 317 patients. Acta Haematol. 1999;102(2):83\u20138.","journal-title":"Acta Haematol"},{"issue":"11","key":"3768_CR8","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMcpc0800380","volume":"358","author":"JS Abramson","year":"2008","unstructured":"Abramson JS, Kotton CN, Elias N, Sahani DV, Hasserjian RP. Case records of the Massachusetts general hospital. Case 8-2008. A 33-year-old man with fever, abdominal pain, and pancytopenia after renal transplantation. N Engl J Med. 2008;358(11):1176\u201387.","journal-title":"N Engl J Med"},{"issue":"3","key":"3768_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.gtc.2018.04.009","volume":"47","author":"BP Sjoberg","year":"2018","unstructured":"Sjoberg BP, Menias CO, Lubner MG, Mellnick VM, Pickhardt PJ. Splenomegaly: A combined clinical and radiologic approach to the differential diagnosis. Gastroenterol Clin North Am. 2018;47(3):643\u201366.","journal-title":"Gastroenterol Clin North Am"},{"issue":"2","key":"3768_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.hoc.2012.02.005","volume":"26","author":"G Motyckova","year":"2012","unstructured":"Motyckova G, Steensma DP. Why does my patient have lymphadenopathy or splenomegaly? Hematol Oncol Clin North Am. 2012;26(2):395\u2013408. ix.","journal-title":"Hematol Oncol Clin North Am"},{"key":"3768_CR11","doi-asserted-by":"crossref","unstructured":"Maillot J, Malfuson JV, Lazure T, Benoist S, Cremades A, Hornez E et al. Diagnostic splenectomy: characteristics, Pre-Operative investigations, and identified pathologies for 20 patients. J Clin Med. 2021;10(7).","DOI":"10.3390\/jcm10071519"},{"issue":"4","key":"3768_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/000313481508100434","volume":"81","author":"G Pata","year":"2015","unstructured":"Pata G, Damiani E, Tognali D, Solaini L, Watt J, Ragni F. Outcomes of open splenectomy for hematologic malignancy with splenomegaly: a contemporary perspective. Am Surg. 2015;81(4):414\u201320.","journal-title":"Am Surg"},{"issue":"6","key":"3768_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/SLA.0b013e318278d1bf","volume":"258","author":"T Taner","year":"2013","unstructured":"Taner T, Nagorney DM, Tefferi A, Habermann TM, Harmsen WS, Slettedahl SW, et al. Splenectomy for massive splenomegaly: long-term results and risks for mortality. Ann Surg. 2013;258(6):1034\u20139.","journal-title":"Ann Surg"},{"issue":"2","key":"3768_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3324\/haematol.2013.092460","volume":"99","author":"SY Kristinsson","year":"2014","unstructured":"Kristinsson SY, Gridley G, Hoover RN, Check D, Landgren O. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica. 2014;99(2):392\u20138.","journal-title":"Haematologica"},{"key":"3768_CR15","doi-asserted-by":"crossref","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C et al. A review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017;18(2).","DOI":"10.3390\/ijms18020441"},{"key":"3768_CR16","unstructured":"Rajkumar V, Dumpa V. Lysosomal Storage Disease. StatPearls. Treasure Island (FL)2022."},{"issue":"2","key":"3768_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2021.01.002","volume":"132","author":"EC Daykin","year":"2021","unstructured":"Daykin EC, Ryan E, Sidransky E. Diagnosing neuronopathic gaucher disease: new considerations and challenges in assigning gaucher phenotypes. Mol Genet Metab. 2021;132(2):49\u201358.","journal-title":"Mol Genet Metab"},{"issue":"4 Suppl 5","key":"3768_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","volume":"41","author":"GM Pastores","year":"2004","unstructured":"Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, et al. Therapeutic goals in the treatment of gaucher disease. Semin Hematol. 2004;41(4 Suppl 5):4\u201314.","journal-title":"Semin Hematol"},{"issue":"1","key":"3768_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13023-022-02573-6","volume":"17","author":"A Dardis","year":"2022","unstructured":"Dardis A, Michelakakis H, Rozenfeld P, Fumic K, Wagner J, Pavan E, et al. Patient centered guidelines for the laboratory diagnosis of gaucher disease type 1. Orphanet J Rare Dis. 2022;17(1):442.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3768_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1148\/radiol.2015150887","volume":"279","author":"KU Chow","year":"2016","unstructured":"Chow KU, Luxembourg B, Seifried E, Bonig H. Spleen size is significantly influenced by body height and sex: establishment of normal values for spleen size at US with a cohort of 1200 healthy individuals. Radiology. 2016;279(1):306\u201313.","journal-title":"Radiology"},{"issue":"3","key":"3768_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.blre.2008.10.001","volume":"23","author":"AL Pozo","year":"2009","unstructured":"Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev. 2009;23(3):105\u201311.","journal-title":"Blood Rev"},{"issue":"10","key":"3768_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0895-4356(01)00372-9","volume":"54","author":"SC Bagley","year":"2001","unstructured":"Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol. 2001;54(10):979\u201385.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"3768_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1159\/000326667","volume":"47","author":"A Lal","year":"2003","unstructured":"Lal A, Ariga R, Gattuso P, Nemcek AA, Nayar R. Splenic fine needle aspiration and core biopsy. A review of 49 cases. Acta Cytol. 2003;47(6):951\u20139.","journal-title":"Acta Cytol"},{"issue":"9","key":"3768_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/jcu.20390","volume":"35","author":"P Liang","year":"2007","unstructured":"Liang P, Gao Y, Wang Y, Yu X, Yu D, Dong B. US-guided percutaneous needle biopsy of the spleen using 18-gauge versus 21-gauge needles. J Clin Ultrasound. 2007;35(9):477\u201382.","journal-title":"J Clin Ultrasound"},{"issue":"3","key":"3768_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1148\/radiol.11110333","volume":"260","author":"MD McInnes","year":"2011","unstructured":"McInnes MD, Kielar AZ, Macdonald DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology. 2011;260(3):699\u2013708.","journal-title":"Radiology"},{"issue":"1","key":"3768_CR26","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1038\/s41598-021-82296-z","volume":"11","author":"I Motta","year":"2021","unstructured":"Motta I, Consonni D, Stroppiano M, Benedetto C, Cassinerio E, Tappino B, et al. Predicting the probability of gaucher disease in subjects with splenomegaly and thrombocytopenia. Sci Rep. 2021;11(1):2594.","journal-title":"Sci Rep"},{"issue":"4","key":"3768_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/ejh.12596","volume":"96","author":"I Motta","year":"2016","unstructured":"Motta I, Filocamo M, Poggiali E, Stroppiano M, Dragani A, Consonni D, et al. A multicentre observational study for early diagnosis of gaucher disease in patients with splenomegaly and\/or thrombocytopenia. Eur J Haematol. 2016;96(4):352\u20139.","journal-title":"Eur J Haematol"},{"issue":"1","key":"3768_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ajh.21888","volume":"86","author":"PK Mistry","year":"2011","unstructured":"Mistry PK, Cappellini MD, Lukina E, Ozsan H, Mach Pascual S, Rosenbaum H, et al. A reappraisal of gaucher disease-diagnosis and disease management algorithms. Am J Hematol. 2011;86(1):110\u20135.","journal-title":"Am J Hematol"},{"issue":"2","key":"3768_CR29","first-page":"119","volume":"7","author":"A Mokhtariye","year":"2019","unstructured":"Mokhtariye A, Hagh-Nazari L, Varasteh AR, Keyfi F. Diagnostic methods for lysosomal storage disease. Rep Biochem Mol Biol. 2019;7(2):119\u201328.","journal-title":"Rep Biochem Mol Biol"},{"issue":"3","key":"3768_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00428-008-0651-4","volume":"453","author":"JP Oliveira","year":"2008","unstructured":"Oliveira JP, Valbuena C, Baldaia Moreira A, Fonseca E, Soares C, Le\u00e3o Teles E, et al. Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson-Fabry disease. Virchows Arch. 2008;453(3):291\u2013300.","journal-title":"Virchows Arch"},{"issue":"2","key":"3768_CR31","doi-asserted-by":"publisher","first-page":"8814","DOI":"10.4081\/hr.2021.8814","volume":"13","author":"G Auteri","year":"2021","unstructured":"Auteri G, Bartoletti D, Bertuzzi C, Bacci F, Tonini V, Catani L, et al. The diagnostic role of next generation sequencing in Uncovering isolated splenomegaly: A case report. Hematol Rep. 2021;13(2):8814.","journal-title":"Hematol Rep"},{"issue":"2","key":"3768_CR32","doi-asserted-by":"publisher","first-page":"e00527","DOI":"10.1002\/mgg3.527","volume":"7","author":"A Gheldof","year":"2019","unstructured":"Gheldof A, Seneca S, Stouffs K, Lissens W, Jansen A, Laeremans H, et al. Clinical implementation of gene panel testing for lysosomal storage diseases. Mol Genet Genomic Med. 2019;7(2):e00527.","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"3768_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jmoldx.2020.01.010","volume":"22","author":"A Zanetti","year":"2020","unstructured":"Zanetti A, D\u2019Avanzo F, Bertoldi L, Zampieri G, Feltrin E, De Pascale F, et al. Setup and validation of a targeted Next-Generation sequencing approach for the diagnosis of lysosomal storage disorders. J Mol Diagn. 2020;22(4):488\u2013502.","journal-title":"J Mol Diagn"},{"issue":"1","key":"3768_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-2141.2012.09146.x","volume":"158","author":"F Rodeghiero","year":"2012","unstructured":"Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol. 2012;158(1):16\u201329.","journal-title":"Br J Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03768-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03768-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03768-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:48:14Z","timestamp":1749206894000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03768-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3768"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03768-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the independent scientific committee (CPP Ouest IV, France) and performed in accordance with the Declaration of Helsinki and applicable laws. Patients (or legal representatives, if applicable) signed an informed consent form prior to participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DG: Received honoraria and\/or research support from Sanofi. LT: Received honoraria and\/or research support from Sanofi. TS: Received honoraria from Sanofi for lectures. RC: Received honoraria and\/or research support from Genzyme\/Sanofi, Sandoz, Novartis, and BeiGene. MM: Received travel grants and speaker honoraria from Amicus, Genzyme\/Sanofi, and Shire\/Takeda. AL: Employe of Sanofi and may hold shares and\/or stock options in the company. FB: Novartis, Sanofi, Octapharma, and Incyte. CR: Received reimbursement of expenses and honorarium for lectures from Sanofi and Shire. GU: Received honoraria from Sanofi and Novartis for lectures. MGB: Received honoraria from Sanofi and Takeda for scientific board lectures. LS: None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}